Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical doxepin versus clemastine for post-burn pruritus
NL-OMON25795Phase 4Active, not recruiting
- Sponsor
- Association of Dutch Burn Centres
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in pruritus comparing Topical doxepin with Oral clemastine control (2 arms). Primary endpoint: Change in mean pruritus intensity. Started Dec 2013; status: active, not recruiting.
02
Drugs
doxepinclemastine
03
Conditions
pruritus
Beyond the preview
Go deeper on NL-OMON25795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25795.